On ****, 2024, Amy Vaccine Co., Ltd. submitted the latest monthly securities report to Hong Kong Exchanges and Clearing Limited, reporting the company's equity changes as of May 31st, 2024. The report shows that there was no change in Amy Vaccine's H shares and domestic shares in the past month, with a balance of 492,173,711 shares for H shares and 718,888,888 shares for domestic shares. The company's registered share capital remains at RMB 1,211,062,599. In addition, under the company's share option plan, as of the end of the month, there were 3,276,000 employee share options issued before the initial public offering, and no new shares were issued this month. Amy Vaccine has confirmed that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Listing Rules of the Hong Kong Stock Exchange.

On ****, 2024, Amy Vaccine Co., Ltd. submitted the latest monthly securities report to Hong Kong Exchanges and Clearing Limited, reporting the company's equity changes as of May 31st, 2024. The report shows that there was no change in Amy Vaccine's H shares and domestic shares in the past month, with a balance of 492,173,711 shares for H shares and 718,888,888 shares for domestic shares. The company's registered share capital remains at RMB 1,211,062,599. In addition, under the company's share option plan, as of the end of the month, there were 3,276,000 employee share options issued before the initial public offering, and no new shares were issued this month. Amy Vaccine has confirmed that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Listing Rules of the Hong Kong Stock Exchange.